CIK 0001549595 · Large accelerated filer
Nurix Therapeutics, Inc.
Sign in to watch- Ticker
- NRIX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Nov 30
- Incorporated
- DE
- Entity type
- operating
- EIN
- 270838048
- Phone
- (415) 660-5320
- Business address
- 1600 SIERRA POINT PKWY, BRISBANE, CA, 94005
- Former names
- Nurix, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,712,859
- in 10 filings, $1.0M under 10b5-1 plans
Net −$1,712,859. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-01-30 | van Houte Hans Chief Financial Officer | Option exercise | +2,859 | 49,088 | ||
| 2026-01-30 | van Houte Hans Chief Financial Officer | Sale | −3,588 | $16.58 | $59K | 45,500 |
| 2026-01-30 | van Houte Hans Chief Financial Officer | Sale | −73 | $17.37 | $1K | 45,427 |
| 2026-01-30 | van Houte Hans Chief Financial Officer | Option exercise · Restricted Stock Units | −2,887 | 0 | ||
| 2026-01-30 | van Houte Hans Chief Financial Officer | Option exercise · Restricted Stock Units | −2,000 | 2,000 | ||
| 2026-01-30 | van Houte Hans Chief Financial Officer | Option exercise · Restricted Stock Units | −3,750 | 18,750 | ||
| 2026-01-30 | van Houte Hans Chief Financial Officer | Option exercise · Restricted Stock Units | −2,859 | 25,725 | ||
| 2026-01-30 | Ring Christine Chief Legal Officer | Option exercise | +1,925 | 52,822 | ||
| 2026-01-30 | Ring Christine Chief Legal Officer | Option exercise | +2,000 | 54,822 | ||
| 2026-01-30 | Ring Christine Chief Legal Officer | Option exercise | +3,750 | 58,572 | ||
| 2026-01-30 | Ring Christine Chief Legal Officer | Option exercise | +2,859 | 61,431 | ||
| 2026-01-30 | Ring Christine Chief Legal Officer | Sale | −4,333 | $16.58 | $72K | 57,098 |
| 2026-01-30 | Ring Christine Chief Legal Officer | Sale | −88 | $17.37 | $2K | 57,010 |
| 2026-01-30 | Ring Christine Chief Legal Officer | Option exercise · Restricted Stock Units | −1,925 | 0 | ||
| 2026-01-30 | Ring Christine Chief Legal Officer | Option exercise · Restricted Stock Units | −2,000 | 2,000 | ||
| 2026-01-30 | Ring Christine Chief Legal Officer | Option exercise · Restricted Stock Units | −3,750 | 18,750 | ||
| 2026-01-30 | Ring Christine Chief Legal Officer | Option exercise · Restricted Stock Units | −2,859 | 25,725 | ||
| 2026-01-30 | Hansen Gwenn Chief Scientific Officer | Option exercise | +3,207 | 79,958 | ||
| 2026-01-30 | Hansen Gwenn Chief Scientific Officer | Option exercise | +2,000 | 81,958 | ||
| 2026-01-30 | Hansen Gwenn Chief Scientific Officer | Option exercise | +3,750 | 85,708 |
Page 8 of 20 · 381 trades